No insider purchase over the last 90 days. The latest, by 조관구, was filed 06 Apr 2026.
Quratis Inc.: what insiders have been doing
Quratis Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). In the past year (31 October 2025 to 31 October 2026), 14 filings came from 5 insiders.
Open-market activity splits into 8 purchases totalling €19.1M and 4 sales; 4 insiders sit on the buying side and 3 insiders on the selling side. No amount is published for 10 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 major shareholder. Biggest ticket of the year: €18.2M, bought by 인벤티지랩 and made public on 6 March 2026.
The last insider purchase was made public on 6 April 2026, 217 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. The shorter that gap, the sooner other investors can see what insiders have done.
With 14 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Looking back to 2023, when coverage begins, insiders filed 30 purchases and 14 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySale+1 other insider
Since the insiders bought
- -66.4%Entry ₩920 · Close at T+90 ₩309
- -58.2%Entry ₩1,001 · Close at T+90 ₩418
- -59.7%Entry ₩1,207 · Close at T+90 ₩487
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 43,256 sharesShareKRXDART:20260810000704
- Other0DART
- 13,401,937 sharesShareKRXDART:20260810000416
- 41,942,941 sharesShareKRXDART:20260810000597
- 0KRXDART:20260406001337
- 70,000 sharesKRXDART:20260406001500Canonical exit: 1 Jul 2026 (T+90)
- 15,077,179 sharesKRXDART:20260402001034
- 9,891,197 sharesShareKRXDART:20260320000992Canonical exit: 15 Jun 2026 (T+90)
- 9,891,197 sharesKRXDART:20260320000975Canonical exit: 15 Jun 2026 (T+90)
- 45,537,255 shares@ ₩631.00100.0% of flowShareKRXDART:20260306000952Canonical exit: 11 Jun 2025 (T+90)
- 2,377,179 shares@ ₩631.005.88% mcap100.0% of flowShareKRXDART:20260306001004Canonical exit: 4 Jun 2026 (T+90)
- 370,854 sharesKRXDART:20260306000943Canonical exit: 27 May 2026 (T+90)
- ●Executives0DART
- 9,709,643 sharesShareKRXDART:20251105000287Canonical exit: 3 Feb 2026 (T+90)
- 6,138,216 sharesKRXDART:20251105000267Canonical exit: 28 Jan 2026 (T+90)
- 402,240 sharesKRXDART:20250507000583
- 80,000 sharesShareKRXDART:20250507000574
- 1,164,144 sharesKRXDART:20241217000418
- 3,110,854 sharesKRXDART:20241202000327
- 7,700,000 sharesKRXDART:20241121000474Canonical exit: 14 Feb 2025 (T+90)
- 7,700,000 sharesShareKRXDART:20241121000464Canonical exit: 19 Feb 2025 (T+90)
- 213,612 sharesKRXDART:20241118000332
- 3,110,854 sharesKRXDART:20241118000268Canonical exit: 9 Feb 2025 (T+90)
- 5,000,000 sharesShareKRXDART:20241107000343Canonical exit: 5 Feb 2025 (T+90)
25 of 66 declarations
About Quratis Inc.
큐라티스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
